Founded in 2023 in Lund, Sweden, Cytely builds a hardware-agnostic software platform that automates image acquisition, quantifies entire samples, and delivers statistically robust, analysis-ready data in real time. By turning traditional microscopes into measurement engines, the company eliminates weeks of manual cell assessment and has been shown to cut analysis time by 75% in commercial labs. Early adopters such as Lund University now process nearly 100% of sample data, uncovering previously hidden cellular mechanisms, while a cancer research lab reported annual savings of €300k and a nanowire biotech firm increased R&D throughput by 40%. The platform already supports research in virology, oncology, and metabolic diseases and is positioned as a democratizing alternative to costly high-throughput imaging rigs. With the latest funding, Cytely plans to add intelligent acquisition tools that work across all microscope brands and introduce one-click workflows and a shared protocol network, paving the way for predictive and partially autonomous research. The company operates with team members in Lund, San Diego, and Singapore and is part of the SmiLe Venture Hub portfolio. The recent €3 million raise provides fresh capital for product expansion, though revenue figures have not been disclosed.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2025